
Tissue Sectioning Market Report 2026
Global Outlook – By Product (Accessories And Consumables, Instruments, Services), By Technology (Automatic, Manual, Semi-Automatic), By Application (Diagnosis, Research), By End-User (Clinics, Diagnostic Laboratories, Hospitals, Research Centers) - Market Size, Trends, And Global Forecast 2026-2035
Tissue Sectioning Market Overview
• Tissue Sectioning market size has reached to $0.83 billion in 2025 • Expected to grow to $1.28 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: Rising Surgical Procedures Propelling Tissue Sectioning Market Growth • Market Trend: Innovative Technologies Revolutionize Tissue Sectioning Analysis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Tissue Sectioning Market?
Tissue sectioning is a crucial technique in histology and pathology to prepare thin tissue slices for microscopic examination. This process is essential for studying the microscopic structure of tissues and understanding the pathological changes associated with diseases. The main products of tissue sectioning are accessories and consumables, instruments, and services. Accessories and consumables are essential items used during tissue sectioning to support and facilitate the process. The technologies including automatic, manual, and semi-automatic to provide diagnosis and research applications by clinics, diagnostic laboratories, hospitals, and research center end users.
What Is The Tissue Sectioning Market Size and Share 2026?
The tissue sectioning market size has grown strongly in recent years. It will grow from $0.83 billion in 2025 to $0.91 billion in 2026 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to increasing volume of diagnostic pathology procedures, expansion of hospital laboratory infrastructure, rising demand for cancer diagnostics, growth in biomedical research activities, wider adoption of histology-based testing.What Is The Tissue Sectioning Market Growth Forecast?
The tissue sectioning market size is expected to see strong growth in the next few years. It will grow to $1.28 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing investments in advanced diagnostic laboratories, rising adoption of digital pathology workflows, growing demand for personalized medicine diagnostics, expansion of academic and clinical research programs, increasing focus on laboratory automation. Major trends in the forecast period include increasing adoption of automated tissue sectioning systems, rising demand for high-precision microtomes and cryostats, growing use of disposable and standardized consumables, expansion of workflow integration in histopathology labs, enhanced focus on reproducibility and section quality.Global Tissue Sectioning Market Segmentation
1) By Product: Accessories And Consumables, Instruments, Services 2) By Technology: Automatic, Manual, Semi-Automatic 3) By Application: Diagnosis, Research 4) By End-User: Clinics, Diagnostic Laboratories, Hospitals, Research Centers Subsegments: 1) By Accessories And Consumables: Microtome Blades, Staining Reagents, Tissue Embedding Media, Mounting Media, Disposable Consumables (Slides, Coverslips) 2) By Instruments: Microtomes (Manual, Semi-Automated, Fully Automated), Cryostats, Tissue Processors, Tissue Embedding Stations, Sectioning Systems 3) By Services: Maintenance And Repair Services, Calibration Services, Installation Services, Training ServicesWhat Is The Driver Of The Tissue Sectioning Market?
The rising surgical procedures are expected to propel the growth of the tissue sectioning market going forward. Surgical procedures are medical interventions involving instruments to diagnose, treat, or repair the body. The rise in surgical procedures is due to advancements in medical technology, demographic changes, and shifts in healthcare practices. Tissue sectioning aids surgical procedures by providing precise, thin tissue slices for histological analysis, enabling accurate diagnosis, treatment planning, and transplantation. For instance, in April 2025, according to the Australian Institute of Health and Welfare, an Australia-based government organization, reported that in 2023–24, public hospitals recorded 778,500 admissions from elective surgery waitlists, marking a 5.8% rise compared with 735,500 admissions in 2022–23. Therefore, rising surgical procedures are driving the tissue sectioning industry.Key Players In The Global Tissue Sectioning Market
Major companies operating in the tissue sectioning market are Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio‑Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo‑Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik LabsGlobal Tissue Sectioning Market Trends and Insights
Major companies operating in the tissue sectioning market are developing advanced technologies, such as next-generation spatial gene expression technology, to enhance tissue analysis and diagnostics. Next-generation spatial gene expression technology allows for the detailed mapping of gene activity within tissue sections, providing insights into the spatial organization of gene expression and tissue architecture. For instance, in March 2024, 10x Genomics, a US-based biotechnology company, launched Visium HD, a next-generation spatial gene expression technology that enables precise gene expression mapping in detailed anatomical structures. It is designed to provide high-resolution spatial gene expression data at single-cell scale resolution from formalin-fixed, paraffin-embedded (FFPE) tissue sections. This technology allows for comprehensively characterizing FFPE tissue sections by measuring whole transcriptome spatial gene expression at single-cell resolution.What Are Latest Mergers And Acquisitions In The Tissue Sectioning Market?
In May 2024, Bruker Corporation, a US-based company, acquired NanoString Technologies for an undisclosed amount. With this acquisition, Bruker expanded its product portfolio with state-of-the-art spatial gene expression tools, enhancing its ability to provide detailed insights into tissue morphology and gene expression. NanoString Technologies is a US-based biotech company that offers various platforms and technologies for analyzing gene and protein expression in tissue sections.Regional Outlook
North America was the largest region in the tissue sectioning market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Tissue Sectioning Market?
The tissue sectioning market consists of revenues earned by entities by providing services such as tissue processing, microtomy, staining, and slide preparation. The market value includes the value of related goods sold by the service provider or included within the service offering. The tissue sectioning market also includes sales of microtome, paraffin dispenser, water bath, and section mounting equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Tissue Sectioning Market Report 2026?
The tissue sectioning market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tissue sectioning industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Tissue Sectioning Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $0.91 billion |
| Revenue Forecast In 2035 | $1.28 billion |
| Growth Rate | CAGR of 9.9% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Technology, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Danaher Corporation, Leica Biosystems Nussloch GmbH, Sakura Finetek USA Inc., Ted Pella Inc., Milestone Srl, Diapath S.p.A., Bio‑Optica Milano S.p.A, MEDITE Medical GmbH, PathnSitu Biotechnologies Pvt Ltd, Tanner Scientific Inc., Boeckeler Instruments Inc., SLEE Medical GmbH, Amos Scientific PTY. LTD., SM Scientific Instruments Pvt. Ltd., Bright Instrument Co. Ltd., RWD Life Science Co. Ltd., Hacker Instruments & Industries Inc., MICROM International GmbH, Epredia Inc, Histo‑Line Laboratories, PHC Holdings Co. Ltd, AGD Biomedicals Pvt Ltd, Avantik Labs |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
